Presentation TCT 2025 TCT 61: Comparative Analysis of Composite Outcomes for Double vs Triple Therapy in Patients with Atrial Fibrillation Post Percutaneous Coronary Intervention Presenter: Khaled Elnaggar October 28, 2025
Presentation TCT 2025 TCT 998: Dual Antiplatelet Therapy (DAT) versus Triple Therapy (TAT) post Percutaneous Coronary Intervention (PCI) in patients requiring Chronic Anticoagulation: Meta-analysis. Presenter: Kanishk Aggarwal October 27, 2025
Presentation TCT 2025 TCT 481: Strike Early, Strike Strong—But Retest Early as Well: Two-Week LDL-C Assessment Accurately Identifies Non-Responders to Triple Oral Lipid-Lowering Therapy in ACS Patients Undergoing PCI Presenter: Kunal Mahajan October 27, 2025
Presentation TCT 2025 TCT 475: Impact of Elevated Lipoprotein(a) on LDL Cholesterol Target Attainment Following PCI for Acute Coronary Syndrome Despite Intensive Triple Oral Lipid-Lowering Therapy: A Retrospective Cohort Study Presenter: Kunal Mahajan October 27, 2025
Presentation TCT 2025 Antithrombotic Therapies in ACS: Atrial Fibrillation - Triple Therapy, Triple Threat! Presenter: Usman Baber October 26, 2025
Presentation TCT 2023 TCT 525: The Prevalence of Bleeding and Ischemic Outcomes in Patients on Triple Therapy in a Real-Practice Registry of Percutaneous Coronary Interventions Presenter: Eva Woelders October 25, 2023
Presentation TCT 2022 TCT 20: Relative benefit of double versus triple antithrombotic therapy in patients with atrial fibrillation randomized earlier versus later after index coronary event: Insights from the AUGUSTUS Trial Presenter: Alexander Fanaroff September 17, 2022
Presentation TCT 2020 COBRA-REDUCE: Randomized Trial of COBRA PzF Stenting to REDUCE Duration of Triple Therapy Presenter: Robert A. Byrne October 17, 2020
Presentation TCT 2019 Case 3: A Patient With AF and ACS Presenter: C. Michael Gibson September 28, 2019
Presentation TCT 2019 Case 2: A Patient With Complex Disease Who Requires Noncardiac Surgery Presenter: Sunil Rao September 28, 2019
Presentation TCT 2019 Case 1: A Complex Multivessel PCI in an Elderly Woman Presenter: James Hermiller September 28, 2019
Presentation TCT 2019 Approaches to Reduce Bleeding Risk Post PCI in Patients Requiring OAC: Is There Any Role for ASA? Presenter: C. Michael Gibson September 28, 2019
Presentation TCT 2019 Role of New-Gen DES in Patients at HBR: Does Stent Type Matter? Presenter: Ajay Kirtane September 28, 2019
Presentation TCT 2019 Welcome, Introductions, and Session Goals Presenter: Roxana Mehran September 28, 2019
Presentation TCT 2019 AFib Patients at High Ischemic Risk Post-PCI: Role of Triple Therapy or Potent P2Y12 Inhibition? Presenter: Dominick Angiolillo September 27, 2019
Presentation TCT 2018 Is There Still a Role for Triple Therapy Based on Recent Studies? Presenter: Walter Desmet, Guy J. Friedrich September 22, 2018
Presentation TCT 2018 Case Conclusion Presenter: Philip M. Urban, Robert W. Yeh, Michael A. Kutcher, Michelle O'Donoghue, Elmir Omerovic, Manel Sabate, Daniel I. Simon, Giuseppe Tarantini September 22, 2018
Presentation TCT 2018 DAPT Duration Case Presentation #2: PCI in Stable CAD With LMCAD and MVD, Case Introduction Presenter: Philip M. Urban, Robert W. Yeh, Michael A. Kutcher, Michelle O'Donoghue, Elmir Omerovic, Manel Sabate, Daniel I. Simon, Giuseppe Tarantini September 22, 2018
Presentation TCT 2018 DAPT Duration Case Presentation #1: NSTEMI in a High Bleeding Risk Patient, Case Introduction Presenter: Philip M. Urban, Robert W. Yeh, Michael A. Kutcher, Michelle O'Donoghue, Elmir Omerovic, Manel Sabate, Daniel I. Simon, Giuseppe Tarantini September 22, 2018
Presentation TCT 2018 Stent Selection for 1-3 Month DAPT: Current Evidence, Ongoing Studies Presenter: Philip M. Urban, Robert W. Yeh, Stephan Windecker September 22, 2018